OpenAlex
PricingAboutJobs
Log inGet started
Work

JAK1 inhibition with abrocitinib reprograms cutaneous immunity and suppresses immune trafficking in chronic pruritus of unknown origin

HTML

Year: 2026
Type: article
Source: Zenodo (CERN European Organization for Nuclear Research)
DOI: 10.5281/zenodo.21996288
Authors: Shahsavari, Shahin, Furge, Rachel, Vats, Kavita, Bhagchandani, Perya, Shahsavari, Shirin, Phillips, Savannah, Patel, Jay, Rajeh, Ahmad, bordeaux, Zachary, Parthasarathy, Varsha, Cornman, Hannah, Wilmer, Joshua, Wang, Jonathan, Fayyad, Deena, Afzal, Shabnam, Adawi, Waleed, Hernandez, Alexei, Vaddaraju, Vedha, Prichard, Thomas, (Penet) Vidaver, Marie-France, Dillen, Carly, kwatra, madan, Xu, Alexander, Kwatra, Shawn
Institutions: University of Maryland, Baltimore, University of Maryland School of Medicine, University of Maryland, College Park, University of Pittsburgh, University at Buffalo, State University of New York, Duke University
Language: English

Topic: Dermatology and Skin Diseases
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Keywords: abrocitinib, JAK1 inhibition, skin immunity, pruritus, small molecule therapy
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W7220661566
FWCI:
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security